<p>The effects and mechanisms of a biosynthetic ginsenoside 3β,12β-Di-O-Glc-PPD on non-small cell lung cancer</p>
OncoTargets and Therapy2019Vol. Volume 12, pp. 7375–7385
Citations Over Time
Abstract
The results of the present study suggest that ginsenoside C3C12PPD may serve as a potential therapeutic candidate compound against NSCLC.
Related Papers
- → Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex(2020)62 cited
- → Chemical constituents of Chinese red ginseng(2016)19 cited
- → Photo-Activatable Akt Probe: A New Tool to Study the Akt-Dependent Physiopathology of Cancer Cells(2017)1 cited
- [Oxidative damage effects of A549 and A549-R cells induced by mainstream smoke].(2009)
- Role and mechanism of Gab2 in invasion of human lung cancer A549 cells(2013)